Why Eli Lilly Is a Buy After Earnings. The Stock Got an Upgrade. -- Barrons.com
Berenberg Bank Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,050
Lilly Opens State-of-the-art Research and Development Center in the Boston Seaport
Technology giants are still the "darlings" of Wall Street investment banks! BlackRock Q2 heavily favored Microsoft, Nvidia, while Morgan Stanley aggressively bought Chinese concept stocks.
The position report of "crocodiles" has just been released!
Express News | Eli Lilly : Berenberg Raises Target Price to $1050 From $1000
Eli Lilly and Co To Go Ex-Dividend On August 15th, 2024 With 1.3 USD Dividend Per Share
DBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,060
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years
Lilly, Uber Among the Biggest Recent Winners of the Beat-and-raise Game in the Stock Market
VOO Vs. VTI: Here Are The Key Differences Between Vanguard US Stock Market ETFs Investors Should Know
Today's Analyst Rating | Apple Price Target Raised to $255 by Citi, Microsoft Price Target Raised to $500 by BMO Capital
Eli Lilly Opens R&D Center in Boston Seaport
Express News | Lilly Opens State-of-the-Art Research and Development Center in the Boston Seaport
Deutsche Bank praises Eli Lilly and Co (LLY.US) as a "high-growth unicorn", with a target price skyrocketing to $1025.
Deutsche Bank has upgraded its rating on Eli Lilly and Co (LLY.US) from "hold" to "buy" with a target price increase from $725 to $1025.
Should Investors Buy Eli Lilly's (LLY) Stock After Strong Q2 Results?
Express News | Eli Lilly Files Pricing Term Sheet Related to Offering of Five-Part $5 Bln Aggregate Principal Amount of Notes - SEC Filing
Don't Forget This Startup's Weight-Loss Pill, Analyst Says -- Barrons.com
Weight Loss Drugs Like Ozempic, Zepbound May Reduce Cancer Risks, Studies Suggest
10 Health Care Stocks With Whale Alerts In Today's Session
Eli Lilly Tapping Bond Market for Morphic Deal -- Market Talk